Free Trial

Global Cord Blood (CO) Competitors

Global Cord Blood logo
$1.50 +0.45 (+42.86%)
(As of 12/20/2024 ET)

CO vs. VMD, MRAI, BRTX, OTRK, MGRX, NIVF, GBNHF, CORBF, FMS, and DVA

Should you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Viemed Healthcare (VMD), Marpai (MRAI), BioRestorative Therapies (BRTX), Ontrak (OTRK), Mangoceuticals (MGRX), NewGenIvf Group (NIVF), Greenbrook TMS (GBNHF), Global Cord Blood (CORBF), Fresenius Medical Care (FMS), and DaVita (DVA). These companies are all part of the "miscellaneous health & allied services, not elsewhere classified" industry.

Global Cord Blood vs.

Viemed Healthcare (NASDAQ:VMD) and Global Cord Blood (NYSE:CO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.

Global Cord Blood has higher revenue and earnings than Viemed Healthcare. Global Cord Blood is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viemed Healthcare$214.30M1.45$10.24M$0.2729.56
Global Cord Blood$1.24B0.10$79.04M$0.641.64

Global Cord Blood received 365 more outperform votes than Viemed Healthcare when rated by MarketBeat users. Likewise, 75.88% of users gave Global Cord Blood an outperform vote while only 42.86% of users gave Viemed Healthcare an outperform vote.

CompanyUnderperformOutperform
Viemed HealthcareOutperform Votes
3
42.86%
Underperform Votes
4
57.14%
Global Cord BloodOutperform Votes
368
75.88%
Underperform Votes
117
24.12%

In the previous week, Global Cord Blood had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 1 mentions for Global Cord Blood and 0 mentions for Viemed Healthcare. Global Cord Blood's average media sentiment score of 0.25 beat Viemed Healthcare's score of -0.55 indicating that Global Cord Blood is being referred to more favorably in the news media.

Company Overall Sentiment
Viemed Healthcare Negative
Global Cord Blood Neutral

74.2% of Viemed Healthcare shares are held by institutional investors. 20.0% of Viemed Healthcare shares are held by insiders. Comparatively, 0.5% of Global Cord Blood shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Viemed Healthcare has a net margin of 4.87% compared to Global Cord Blood's net margin of 0.00%. Viemed Healthcare's return on equity of 8.72% beat Global Cord Blood's return on equity.

Company Net Margins Return on Equity Return on Assets
Viemed Healthcare4.87% 8.72% 6.48%
Global Cord Blood N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Viemed Healthcare has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of 0.16, meaning that its share price is 84% less volatile than the S&P 500.

Summary

Viemed Healthcare beats Global Cord Blood on 10 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CO vs. The Competition

MetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE Exchange
Market Cap$127.63M$1.90B$5.01B$19.19B
Dividend YieldN/A7.04%4.87%3.58%
P/E Ratio1.6415.50135.0741.22
Price / Sales0.103.171,120.6317.58
Price / Cash4.199.7740.5821.28
Price / Book0.173.034.755.32
Net Income$79.04M$69.56M$118.50M$989.67M
7 Day PerformanceN/A-4.28%-1.85%-3.45%
1 Month Performance-16.00%-5.33%11.28%-3.73%
1 Year Performance-29.53%-27.35%29.92%12.06%

Global Cord Blood Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CO
Global Cord Blood
N/A$1.50
+42.9%
N/A-16.7%$182.33M$1.24B2.341,202
VMD
Viemed Healthcare
1.7189 of 5 stars
$8.70
-0.5%
N/A+3.6%$338.78M$183.01M32.37630Positive News
MRAI
Marpai
N/A$1.15
-8.0%
$6.00
+421.7%
-47.7%$15.80M$34.87M-0.42150Gap Up
BRTX
BioRestorative Therapies
3.4511 of 5 stars
$1.48
+1.8%
$18.00
+1,119.3%
-11.4%$10.22M$150,000.00-0.917Positive News
OTRK
Ontrak
2.6191 of 5 stars
$1.60
-2.4%
$45.00
+2,712.5%
-76.2%$6.75M$11.24M-0.15250Positive News
MGRX
Mangoceuticals
1.184 of 5 stars
$2.55
-2.3%
N/A-96.2%$6.34M$755,000.00-0.453News Coverage
Positive News
Gap Down
NIVF
NewGenIvf Group
0.4999 of 5 stars
$0.29
-10.1%
N/AN/A$1.06M$5.14M0.00N/AGap Down
GBNHF
Greenbrook TMS
N/A$0.01
-18.0%
N/AN/A$408,000.00$73.79M-0.01430Gap Down
CORBF
Global Cord Blood
N/A$1.26
flat
N/A+19.0%$0.00$196.12M0.001,202
FMS
Fresenius Medical Care
3.4832 of 5 stars
$23.92
+1.1%
$24.30
+1.6%
+11.4%$14.04B$19.24B19.791,358News Coverage
Positive News
DVA
DaVita
4.2591 of 5 stars
$151.63
-0.7%
$161.80
+6.7%
+46.2%$12.43B$12.14B16.4870,000Positive News

Related Companies and Tools


This page (NYSE:CO) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners